05.08.2021, Moscow.
Commitment to evidence-based healthcare relying on research has been destroyed during the COVID-19 pandemic, the Chairman of the Moscow Municipal Scientific Society of Primary Care Doctors, Doctor of Medical Sciences, Professor of the Moscow Medical Academy Pavel Vorobyov said in an interview to the Rossa Primavera News Agency.
“COVID has destroyed the commitment to evidence and evidence-based medicine, to the search for evidence, and to research. Indeed, such research would take only a few days provided a large number of patients is available,” he explained.
The doctor added, “A patient can have acute COVID for two, maximum three weeks. Take a group of 100 such patients and 100 control subjects, and examine them. But this is not done, they do not want to, so they will have no findings.”
The chairman of the Moscow Municipal Scientific Society of Primary Care Doctors answered a question about the efficacy of the antiviral drug products hydroxychloroquine and ivermectin for the treatment of COVID-19. He believes that the efficacy of these drug products has not been demonstrated.
“No appropriate trials of any of the antiviral drug products that I see have been made,” Vorobyov said.
Hydroxychloroquine has an antimalarial effect, and it also acts as an anti-inflammatory and immunosuppressive agent in patients with chronic discoid or systemic lupus erythematosus (SLE), acute and chronic rheumatoid arthritis (RA). Some medical professionals use this drug product for COVID-19, and they report that it is efficient.
Source: Rossa Primavera News Agency
